Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review

 

Get this Report



PayPal Verified Vendor

Rating

4.2 Star Rating for report Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review
4.2 / 5 stars rating
Pages: 25
Price: $300.00

Some of our Clients

Some Research and Expert Clients

Abstract

 
This comprehensive SWOT profile of Osiris Therapeutics Inc provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Osiris Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
 

Description

Osiris Therapeutics Inc (Osiris) is a biotechnology company that conducts research, development and commercialization of stem cell products for the treatment of conditions related to wound, orthopedic, and sports medicine. The company operates through its biosurgery business segment develops new products related to diabetic foot ulcers, venous stasis ulcers, dermal burns, and sports medicine products for motion preservation. The product portfolio of the company includes commercialized products, Grafix, Ovation, OvationOS and Cartiform. The company is headquartered in Columbia, Maryland, the US.

Osiris Therapeutics Inc Key Recent Developments

Jun 26,2017: Osiris Appoints Linda Palczuk to serve as its President & CEO
Jun 26,2017: Osiris Therapeutics appoints Linda Palczuk as president and CEO
May 31,2017: Osiris Appoints David White to its Board of Directors
Apr 13,2017: Osiris Announces Scientific Manuscript Comparing Impact of Preservation Methods on Tissue Integrity and Functionality is Available Electronically in Peer-Reviewed Journal
Apr 04,2017: Osiris Therapeutics to Present 29 Advanced Clinical and Scientific Abstracts, Including a Late-Breaking Abstract on its New Ambient Viable Tissue Preservation Technology
 

Similar Reports

Other reports that may be of interest...

Report... 05IC-GDPH5315FSAGilead Sciences Inc (GILD) - Financial and Strategic SWOT Analys...Apr 2017
Report... 05IC-GDPH59772FSATG Therapeutics Inc (TGTX) - Financial and Strategic SWOT Analys...Jul 2017
Report... 05IC-GDPH42160FSAGeron Corp (GERN) - Financial and Strategic SWOT Analysis ReviewMay 2017
Report... 05IC-GDPH81703FSANuo Therapeutics Inc (NUOTQ) - Financial and Strategic SWOT Anal...Jul 2017
Report... 05IC-GDPH479FSAAnalogic Corp (APOG) - Financial and Strategic SWOT Analysis Rev...Nov 2016
Report... 05IC-GDPH57980FSAEnzo Biochem Inc (ENZ) - Financial and Strategic SWOT Analysis R...Nov 2016
Report... 05IC-GDPH1307FSABiogen Inc (BIIB) - Financial and Strategic SWOT Analysis ReviewMar 2017
Report... 05IC-GDPH23482SAMedStar Health - Strategic SWOT Analysis ReviewNov 2016
Report... 05IC-GDPH23492SAMercy - Strategic SWOT Analysis ReviewAug 2017
Report... 05IC-GDPH32199FSAPhibro Animal Health Corp (PAHC) - Financial and Strategic SWOT ...Nov 2016

Report Source Information

Supplied by: Research and Experts 
Date Published: 2017-08-07 

Report: Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review

 

Contents

Table of Contents

Section 1 - About the Company

Osiris Therapeutics Inc - Key Information
Osiris Therapeutics Inc - Overview
Osiris Therapeutics Inc - Key Employees
Osiris Therapeutics Inc - Key Employee Biographies
Osiris Therapeutics Inc - Key Operational Heads
Osiris Therapeutics Inc - Major Products and Services
Osiris Therapeutics Inc - History
Osiris Therapeutics Inc - Company Statement
Osiris Therapeutics Inc - Locations And Subsidiaries
Osiris Therapeutics Inc - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

Osiris Therapeutics Inc - Business Description
Osiris Therapeutics Inc - Corporate Strategy
Osiris Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Osiris Therapeutics Inc - Strengths
Osiris Therapeutics Inc - Weaknesses
Osiris Therapeutics Inc - Opportunities
Osiris Therapeutics Inc - Threats
Osiris Therapeutics Inc - Key Competitors

Section 3 - Company Financial Performance Charts

Osiris Therapeutics Inc - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer


Note*: Some sections may be missing if data is unavailable for the company
 

List of Tables

List of Tables

Osiris Therapeutics Inc, Key Information
Osiris Therapeutics Inc, Key Ratios
Osiris Therapeutics Inc, Share Data
Osiris Therapeutics Inc, Major Products and Services
Osiris Therapeutics Inc, History
Osiris Therapeutics Inc, Key Employees
Osiris Therapeutics Inc, Key Employee Biographies
Osiris Therapeutics Inc, Key Operational Heads
Osiris Therapeutics Inc, Other Locations
Osiris Therapeutics Inc, Subsidiaries
Osiris Therapeutics Inc, Key Manufacturing facilities
Osiris Therapeutics Inc, Key Competitors
Osiris Therapeutics Inc, SWOT Analysis
Osiris Therapeutics Inc, Ratios based on current share price
Osiris Therapeutics Inc, Annual Ratios
Osiris Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 

List of Figures

List of Figures

Osiris Therapeutics Inc, Performance Chart
Osiris Therapeutics Inc, Ratio Charts
 

Scope

The profile contains critical company information including*,

- Business description - A detailed description of the company's operations and business divisions.
- Corporate strategy - Analyst's summarization of the company's business strategy.
- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

 

Classification

Language Code: EN 
Region: United States 
Report Type: Company Reports 
Industry: Life Sciences 
Sector: Life Sciences 
Pages: 25 

Reasons to buy this report

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
 

Similar Reports

Other reports that may be of interest...

Report... 05IC-GDPH5315FSAGilead Sciences Inc (GILD) - Financial and Strategic SWOT Analys...Apr 2017
Report... 05IC-GDPH59772FSATG Therapeutics Inc (TGTX) - Financial and Strategic SWOT Analys...Jul 2017
Report... 05IC-GDPH42160FSAGeron Corp (GERN) - Financial and Strategic SWOT Analysis ReviewMay 2017
Report... 05IC-GDPH81703FSANuo Therapeutics Inc (NUOTQ) - Financial and Strategic SWOT Anal...Jul 2017
Report... 05IC-GDPH479FSAAnalogic Corp (APOG) - Financial and Strategic SWOT Analysis Rev...Nov 2016
Report... 05IC-GDPH57980FSAEnzo Biochem Inc (ENZ) - Financial and Strategic SWOT Analysis R...Nov 2016
Report... 05IC-GDPH1307FSABiogen Inc (BIIB) - Financial and Strategic SWOT Analysis ReviewMar 2017
Report... 05IC-GDPH23482SAMedStar Health - Strategic SWOT Analysis ReviewNov 2016
Report... 05IC-GDPH23492SAMercy - Strategic SWOT Analysis ReviewAug 2017
Report... 05IC-GDPH32199FSAPhibro Animal Health Corp (PAHC) - Financial and Strategic SWOT ...Nov 2016

Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review

Report 05IC-GDPH2234FSA has a rating of 83.5 percent
Figure of merit assessment for report 05IC-GDPH2234FSA

Relevance Rating

The Research and Experts relevance ranting consists of a set of figure of merit (FOM) values that are provided as an indication of the value of the report in the current economic environment.

These FOM values cannot take into account the reason for the clients interest in a report and therefore the client should view these FOM values only as a visual guide. The FOM scores are based on

market interest - how often the report is viewed or purchased,
elapsed time - time since the report was published,
report detail - amount of detail in the report (pages, figures, images, comments etc.) and
price - the price of the report.


Regional Information

Taxonomy

Branch ID: 1555

Taxonomy Location

The taxonomy on the left shows the ancestors of the United States node. This provides an insight into parent categories that may provide reports or articles that may compliment this report. The number in brackets after the node name indicates the number of reports that Research and Experts currently have in the parent category.

Clicking on a parent category will present the list of reports in the parent node in a separate window.

United States

The US has the largest economy in the world. It is highly industrialised and some of the main industries include; petroleum, steel, motor vehicles, aerospace, telecommunications, chemicals, electronics, food processing, consumer goods, lumber and mining.  

The US economy is dealing with slow growth rates, unemployment and increasing national debt since the recession of 2008/2009 however economists expect much higher growth in the US economy in 2014. The IMF expects growth to increase from 1.9% in 2013 to 2.8% in 2014.  The IMF expects a drop in unemployment to 6% in 2014. The indicators are good. The private sector is growing, federal spending will continue and some of the underlying drags on the economy are diminishing. Cheaper energy coming from increased oil exploration, gas fracking and renewables has helped to bring more jobs back to the US. The manufacturing sector is growing again and manufacturing technology is improving. 

There is a shortage of housing as a result of limited construction in recent years. Satisfying this demand should provide a much needed boost for the construction industry. There has also been considerable under investment in many other areas of the economy during the credit crunch and it is expected that there will be growth in the IT sector as companies carry out much needed upgrading of systems. 

Inequality is a major issue in the US economy. More of the wealth is going to the top 1% of high earners and middle incomes are stagnant. Tax reform is necessary for the redistribution of wealth. By putting more money in the pockets of the lower and middle classes the US economy will start to see some real growth.

Researchandexperts.com is a leading source of market research on key industry sectors in the USA.

Useful Links

World Bank Overview of the United States

CIA World Factbook on the United States

The International Monetary Fund on the US Economy

United States

Northern America

Region

 

North America

The term North America usually refers to the US and Canada sometimes including Geenland, Mexico and the islands of Bermuda, St Helena and Saint Pierre et Miquelon.  

North America is dominated by the largest global economy, the United States. The main industries in the US are technology, petroleum, steel, motor vehicles, aerospace, telecommunications, chemicals, electronics, food processing, consumer goods, lumber and mining. The US main tading partners are Canada, China, Mexico, Japan, and Germany. Canada is one of the largest economies in the world and is listed as one of the G8. Canada has a well established services sector along with well established industries in the areas of maufacturing, mining and logging. Canada's main trading partners are US, EU, China and Mexico.

 Research and Experts, the market intelligence platform, provides companies with access to the latest leading industry reports covering the North American region. Our company reports contain the following information; company overviews, key facts, key employees, products and services, as well as financial ratios. Our industry reports are vital sources of detailed historic and forecast values for markets in North America, segmented at category level.

Research and Experts reports also provide regional analysis and analysis of the leading companies in key North American markets.  Researchandexperts.com is a  leading source of market research on North America.

North America

Country

Countries

 

Industry Sector Information

Taxonomy

Branch ID: 205

Taxonomy Location

The taxonomy on the left shows the ancestors of the Life Sciences node. This provides an insight into parent categories that may provide reports or articles that may compliment this report. The number in brackets after the node name indicates the number of reports that Research and Experts currently have in the parent category.

Clicking on a parent category will present the list of reports in the parent node in a separate window.

Life Sciences

The Life Sciences industry includes biotechnology, healthcare, pharmaceuticals, medical devices and diagnostics. The industry is dominated by US companies requiring considerable investment in research and development to stay competitive.  While US companies dominate this space, competition is emerging from smaller companies in Europe and Asia. 

Companies trying to stay competitive or enter new markets in life sciences consult our reports. For example, Plimsoll, in their recent review of global antibiotic manufacturers have reviewed 150 of the largest manufacturers including analysis of  ANTIBIOTICE SA, BAYER HEALTHCARE MANUFACTURING SRL and CIPLA LTD. 

Our reports are a requirement for companies looking for the best competitive intelligence in the life sciences sector providing information on market size, rankings, best trading partners and financial analysis. 

Useful Links

Analytical Life Sciences and Diagnostics Association

German Life Sciences Association

 

Life Sciences

Industry

Industries

 

 

Buy: Osiris Therapeutics Inc (OSIR) - Financial and Strategic SWOT Analysis Review

 

Item Code: 05IC-GDPH2234FSA

 
Licence: Single User
Price: $300.00
 
VAT: 0.0% 
Total: $300.00 

Feedback

Return to Research and Experts

Page created and rendered - Cache updated [1.85409s]

--